Stocks and Investing
Stocks and Investing
Wed, December 2, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Amit Hazan Initiated (TXG) at Hold and Held Target at $150 on, Dec 2nd, 2020
Amit Hazan of Goldman Sachs, Initiated "10x Genomics, Inc." (TXG) at Hold and Held Target at $150 on, Dec 2nd, 2020.
Amit has made no other calls on TXG in the last 4 months.
There are 3 other peers that have a rating on TXG. Out of the 3 peers that are also analyzing TXG, 0 agree with Amit's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Amit
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $145 on, Wednesday, November 11th, 2020
- Derik De Bruin of "B of A Securities" Maintained at Strong Buy with Increased Target to $138 on, Wednesday, September 16th, 2020
- Tycho Peterson of "JP Morgan" Maintained at Buy with Increased Target to $140 on, Tuesday, September 15th, 2020
Contributing Sources